A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

CpG 7909

Trial Locations (2)

52242

University of Iowa, Iowa City

55905

Mayo Clinic, Rochester

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Pfizer

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Iowa

OTHER